Franklin, TN - BioMimetic Therapeutics, Inc. (NASDAQ: BMTI), announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share. After underwriting discounts and commissions and estimated offering expenses, BioMimetic received net proceeds of approximately $45 million. (more…)
WINSTON SALEM, NC – New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs – bringing vital new treatments to patients much more quickly. (more…)
High Point, NC – TransTech Pharma will receive a $50 million up front payment from Forest Laboratories in a collaboration deal that could be worth more than $1.1 billion in potential fees. (more…)
Research Triangle Park, NC – Barcelona-based Grifols, the largest maker of blood plasma products in Europe, has agreed to pay $3.4 billion for Talecris Biotherapeutics Holdings Corp. (more…)
Raleigh, NC - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that it has entered into an agreement to sell $300 million aggregate principal amount of its 2.75% convertible senior notes due 2015. (more…)
Chapel Hill, NC - POZEN Inc. (NASDAQ: POZN), announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration (FDA) approval of VIMOVO™ (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application (IND) and New Drug Application (NDA) for VIMOVO to AstraZeneca over the next few weeks. (more…)
Washington, DC – The U.S. Department of the Treasury today announced the guidelines for applying for the new Therapeutic Discovery Project Program created by the Affordable Care Act. The program will provide tax credits and grants to small firms that show significant potential to produce new and cost-saving therapies, support good jobs and increase U.S. competitiveness. (more…)
Palm Beach Gardens, FL – Aurora Diagnostics, a diagnostic lab and anatomic pathology company, has filed for a $150 million initial public offering of stock. (more…)
Atlanta, GA – Alimera Sciences Inc. developing prescription eye treatments, has raised about $72 million in an initial public offering of stock. (more…)
Research Triangle Park, NC - Sandoz, a unit of Novartis, has agreed to acquire Oriel Therapeutics, a North Carolina-based developer of inhaled drug delivery systems for asthma and chronic obstructive pulmonary diseases. (more…)
